Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Jinlan Pharm-Drugs Technology is a specialized pharmaceutical company focused on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs) and high-end pharmaceutical intermediates. The company operates as a Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO), providing custom synthesis and process optimization services to the global life sciences industry. Their expertise spans several therapeutic categories, including antivirals, oncology, and cardiovascular health. With multiple production bases and R&D centers in China, they support clients from early-stage development through to commercial-scale production. The company is a significant exporter, serving markets in Europe, North America, and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinlan Pharm-Drugs Technology.